Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMC114 (Darunavir) Dose-Finding in PI-Resistant HIV
NCT00964327Phase 2Completed
- Sponsor
- Tibotec
- Start
- Aug 2001
- Primary completion
- Oct 2003
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Tibotec. Started Aug 2001; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00964327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00964327.